The Latest Headlines at American Banking and Market News
Visa (NYSE:V) Trading Up 0.1% on Analyst Upgrade
Visa Inc. (NYSE:V – Get Free Report)’s stock price was up 0.1% during mid-day trading on Friday after Mizuho raised their price target on the stock from $265.00 to $275.00. Mizuho currently has a neutral rating on the stock.... More of this article »
General Electric (NYSE:GE) vs. GE Vernova (NYSE:GEV) Financial Analysis
GE Vernova (NYSE:GEV – Get Free Report) and General Electric (NYSE:GE – Get Free Report) are both large-cap oils/energy companies, but which is the better business? We will compare the two businesses based on the strength... More of this article »
Raymond James Brokers Raise Earnings Estimates for Brookfield Infrastructure Partners LP (TSE:BIP)
Brookfield Infrastructure Partners LP (TSE:BIP – Free Report) – Analysts at Raymond James upped their Q3 2024 EPS estimates for shares of Brookfield Infrastructure Partners in a report released on Wednesday, May 1st.... More of this article »
Wedbush Equities Analysts Decrease Earnings Estimates for Steven Madden, Ltd. (NASDAQ:SHOO)
Steven Madden, Ltd. (NASDAQ:SHOO – Free Report) – Stock analysts at Wedbush lowered their Q3 2024 earnings per share (EPS) estimates for shares of Steven Madden in a research note issued to investors on Wednesday, May... More of this article »
Sidoti Csr Weighs in on Powell Industries, Inc.’s Q3 2024 Earnings (NASDAQ:POWL)
Powell Industries, Inc. (NASDAQ:POWL – Free Report) – Equities researchers at Sidoti Csr raised their Q3 2024 EPS estimates for Powell Industries in a research note issued on Wednesday, May 1st. Sidoti Csr analyst J.... More of this article »
Q3 2024 EPS Estimates for Cameco Co. Lifted by Raymond James (TSE:CCO)
Cameco Co. (TSE:CCO – Free Report) (NYSE:CCJ) – Raymond James boosted their Q3 2024 earnings per share estimates for shares of Cameco in a report released on Tuesday, April 30th. Raymond James analyst B. Macarthur now... More of this article »
Q3 2024 Earnings Estimate for Sarepta Therapeutics, Inc. Issued By Leerink Partnrs (NASDAQ:SRPT)
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) – Investment analysts at Leerink Partnrs raised their Q3 2024 earnings per share estimates for shares of Sarepta Therapeutics in a research report issued to clients... More of this article »
Q3 2024 EPS Estimates for Oaktree Specialty Lending Co. Cut by Analyst (NASDAQ:OCSL)
Oaktree Specialty Lending Co. (NASDAQ:OCSL – Free Report) – B. Riley cut their Q3 2024 earnings per share estimates for shares of Oaktree Specialty Lending in a report issued on Wednesday, May 1st. B. Riley analyst... More of this article »
Starbucks Co. to Post Q3 2024 Earnings of $0.94 Per Share, Wedbush Forecasts (NASDAQ:SBUX)
Starbucks Co. (NASDAQ:SBUX – Free Report) – Analysts at Wedbush cut their Q3 2024 earnings per share (EPS) estimates for shares of Starbucks in a research note issued on Wednesday, May 1st. Wedbush analyst N. Setyan... More of this article »
Sanmina Co. (NASDAQ:SANM) to Post Q3 2024 Earnings of $1.10 Per Share, Sidoti Csr Forecasts
Sanmina Co. (NASDAQ:SANM – Free Report) – Investment analysts at Sidoti Csr lowered their Q3 2024 EPS estimates for shares of Sanmina in a research note issued on Tuesday, April 30th. Sidoti Csr analyst A. Soderstrom... More of this article »
2U (NASDAQ:TWOU) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of 2U (NASDAQ:TWOU – Get Free Report) in a research report issued on Saturday. The firm set a “hold” rating on the software maker’s stock. Other equities research analysts... More of this article »
Equitrans Midstream Co. (NYSE:ETRN) Given Average Recommendation of “Hold” by Brokerages
Equitrans Midstream Co. (NYSE:ETRN – Get Free Report) has earned an average recommendation of “Hold” from the eight analysts that are currently covering the firm, Marketbeat reports. One analyst has rated the stock... More of this article »
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Rating of “Moderate Buy” by Analysts
Shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) have been given an average rating of “Moderate Buy” by the seven research firms that are presently covering the company, Marketbeat Ratings reports.... More of this article »